{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:22:38Z","timestamp":1773282158185,"version":"3.50.1"},"reference-count":45,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Eye Research"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1076\/ceyr.27.5.289.17220","type":"journal-article","created":{"date-parts":[[2003,10,21]],"date-time":"2003-10-21T08:04:40Z","timestamp":1066723480000},"page":"289-299","source":"Crossref","is-referenced-by-count":24,"title":["A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics"],"prefix":"10.1080","volume":"27","author":[{"given":"Ellen J.","family":"Lee","sequence":"first","affiliation":[{"name":"Morton D. Sarver Laboratory for Contact Lens and Cornea Research, School of Optometry, University of California, Berkeley, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan N.","family":"Truong","sequence":"additional","affiliation":[{"name":"Morton D. Sarver Laboratory for Contact Lens and Cornea Research, School of Optometry, University of California, Berkeley, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra N.","family":"Mendoza","sequence":"additional","affiliation":[{"name":"Morton D. Sarver Laboratory for Contact Lens and Cornea Research, School of Optometry, University of California, Berkeley, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.J.","family":"Fleiszig","sequence":"additional","affiliation":[{"name":"Morton D. Sarver Laboratory for Contact Lens and Cornea Research, School of Optometry, University of California, Berkeley, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1972.01000030555018"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.6.2288-2294.1996"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.2.579-586.1997"},{"key":"e_1_2_1_5_1","first-page":"3485","article-title":"Pier GB","volume":"62","author":"Fleiszig SMJ","year":"1994","unstructured":"Fleiszig SMJ, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun. 1994;62: 3485\u20133493.","journal-title":"Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun"},{"key":"e_1_2_1_6_1","first-page":"4072","article-title":"Pier GB","volume":"63","author":"Fleiszig SMJ","year":"1995","unstructured":"Fleiszig SMJ, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun. 1995;63:4072\u20134077.","journal-title":"Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun"},{"key":"e_1_2_1_7_1","first-page":"1541","volume":"63","author":"Apodaca G","year":"1995","unstructured":"Apodaca G, Bomsel M, Lindstedt R, Engel J, Frank D, Mostov KE, Wiener-Kronish J. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: Glycosylation-defective host cells are resistant to bacterial killing. Infect Immun. 1995;63:1541\u20131551.","journal-title":"Wiener-Kronish J. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: Glycosylation-defective host cells are resistant to bacterial killing. Infect Immun"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.10.5530-5537.1999"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.11.6164-6167.1999"},{"key":"e_1_2_1_10_1","first-page":"1453","article-title":"Finck-Barbancon V, Wu C, Fleiszig SMJ","volume":"66","author":"Evans DJ","year":"1998","unstructured":"Evans DJ, Frank DW, Finck-Barbancon V, Wu C, Fleiszig SMJ. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyro-sine kinase activity. Infect Immun. 1998;66:1453\u20131459.","journal-title":"Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyro-sine kinase activity. Infect Immun"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"Cowell BA Weissman BA Yeung KK Johnson L Ho S Van R Bruckner D Mondino B Fleiszig SMJ. Phenotype of Pseudomonas aeruginosa isolates causing corneal infec-tion between 1997 and 2000. Cornea. [In press] 2003.","DOI":"10.1097\/00003226-200303000-00010"},{"key":"e_1_2_1_12_1","first-page":"730","article-title":"Husband A","volume":"17","author":"Cole N","year":"1998","unstructured":"Cole N, Willcox MDP, Fleiszig SMJ, Stapleton F, Bao B, Tout S, Husband A. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res. 1998;17:730\u2013735.","journal-title":"Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200009000-00011"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Khokhar S Sindhu N Mirdha BR. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis. Infection. 2000;28: 149\u2013152.","DOI":"10.1007\/s150100050068"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","unstructured":"Hyndiuk RA Eiferman RA Caldwell DR Rosenwasser GO Santos CI Katz HR Badrinath SS Reddy MK Adenis JP Klauss V. Comparison of ciprofloxacin ophthalmic solu-tion 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers: Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology. 1996;103: 1854\u20131862.","DOI":"10.1016\/S0161-6420(96)30416-8"},{"key":"e_1_2_1_16_1","first-page":"1257","article-title":"the Bacterial Keratitis Study Research Group","volume":"113","author":"O'Brien TP","year":"1995","unstructured":"O'Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P, and the Bacterial Keratitis Study Research Group. Efficacy of ofloxacin vs. cefazolin and tobramycin in the therapy for bacterial keratitis: Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol. 1995;113:1257\u20131265.","journal-title":"Efficacy of ofloxacin vs. cefazolin and tobramycin in the therapy for bacterial keratitis: Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Panda A Ahuja R Sastry SS. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Eye. 1999;13: 744\u2013747.","DOI":"10.1038\/eye.1999.220"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)74449-6"},{"key":"e_1_2_1_19_1","first-page":"500","article-title":"Aprecio RM","volume":"13","author":"Guzek JP","year":"1994","unstructured":"Guzek JP, Chacko D, Kettering JD, Wessels IF, Aprecio RM. Comparison of topical ciprofloxacin to conventional antibi-otic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Cornea. 1994;13:500\u2013504.","journal-title":"Comparison of topical ciprofloxacin to conventional antibi-otic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Cornea"},{"key":"e_1_2_1_20_1","first-page":"143","article-title":"Lee TY, Tang-Liu D, Hubbard BB, Gwon A","volume":"11","author":"Gritz DC","year":"1992","unstructured":"Gritz DC, McDonnell PJ, Lee TY, Tang-Liu D, Hubbard BB, Gwon A. Topical ofloxacin in the treatment of Pseudomonas aeruginosa keratitis in a rabbit model. Cornea. 1992;11:143\u2013147.","journal-title":"Topical ofloxacin in the treatment of Pseudomonas aeruginosa keratitis in a rabbit model. Cornea"},{"key":"e_1_2_1_21_1","first-page":"1559","article-title":"Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections","volume":"28","author":"Steuhl K-P","year":"1987","unstructured":"Steuhl K-P, D\u00f6ring G, Henni A, Thiel H, Botzenhart K. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Oph-thalmol Vis Sci. 1987;28:1559\u20131568.","journal-title":"Invest Oph-thalmol Vis Sci"},{"key":"e_1_2_1_22_1","first-page":"461","article-title":"Gebhardt BM, O'Callaghan RJ","volume":"12","author":"Hobden JA","year":"1993","unstructured":"Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res. 1993;12:461\u2013467.","journal-title":"Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res"},{"key":"e_1_2_1_23_1","first-page":"507","volume":"27","author":"Twining SS","year":"1986","unstructured":"Twining SS, Lohr KM, Moulder JE. The immune system in experimental Pseudomonas keratitis: Model and early effects. Invest Ophthalmol Vis Sci. 1986;27:507\u2013515.","journal-title":"Moulder JE. The immune system in experimental Pseudomonas keratitis: Model and early effects. Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_24_1","first-page":"116","volume":"16","author":"Kessler E","year":"1977","unstructured":"Kessler E, Mondino BJ, Brown SI. The corneal response to Pseudomonas aeruginosa: Histopathological and enzy-matic characterization. Invest Ophthalmol Vis Sci. 1977; 16:116\u2013125.","journal-title":"Brown SI. The corneal response to Pseudomonas aeruginosa: Histopathological and enzy-matic characterization. Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_25_1","first-page":"43","article-title":"Beuerman R","volume":"3","author":"Waterbury L","year":"1987","unstructured":"Waterbury L, Kunysz EA, Beuerman R. Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing. J Ocul Pharmacol. 1987;3:43\u201354.","journal-title":"Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing. J Ocul Pharmacol"},{"key":"e_1_2_1_26_1","first-page":"238","article-title":"Corticosteroids in corneal endothelial wound healing","volume":"17","author":"Singh G","year":"1985","unstructured":"Singh G. Corticosteroids in corneal endothelial wound healing. Ann Ophthalmol. 1985;17:238\u2013243.","journal-title":"Ann Ophthalmol"},{"key":"e_1_2_1_27_1","first-page":"640","article-title":"Kenyon KR","volume":"101","author":"Phillips K","year":"1983","unstructured":"Phillips K, Arffa R, Cintron C, Rose J, Miller D, Kublin CL, Kenyon KR. Effects of prednisolone and medrox-yprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol. 1983;101:640\u2013643.","journal-title":"Effects of prednisolone and medrox-yprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)00963-6"},{"key":"e_1_2_1_29_1","first-page":"528","article-title":"Welsh NH","volume":"74","author":"Carimichael TR","year":"1990","unstructured":"Carimichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol. 1990;74:528\u2013531.","journal-title":"Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","unstructured":"Wilhelmus KR Hyndiuk RA Caldwell DR Abshire RL Folkens AT Godio LB. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis: The Ciprofloxacin Ointment\/Bacterial Keratitis Study Group. Arch Ophthalmol. 1993;111: 1210\u20131208.","DOI":"10.1001\/archopht.1993.01090090062020"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1980.01020040139024"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1985.01050050110028"},{"key":"e_1_2_1_33_1","first-page":"553","article-title":"Treatment of Pseudomonas ker-atitis in the rabbit with antibiotic-steroid combinations","volume":"16","author":"Bohigian GM","year":"1977","unstructured":"Bohigian GM, Foster CS. Treatment of Pseudomonas ker-atitis in the rabbit with antibiotic-steroid combinations. Invest Ophthalmol Vis Sci. 1977;16:553\u2013556.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_34_1","first-page":"126","volume":"96","author":"Davis SD","year":"1978","unstructured":"Davis SD, Sarff LD, Hyndiuk RA. Corticosteroid in experimentally induced Pseudomonas keratitis: Failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy. Arch Ophthalmol. 1978;96:126\u2013128.","journal-title":"Hyndiuk RA. Corticosteroid in experimentally induced Pseudomonas keratitis: Failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy. Arch Ophthalmol"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713689209001777"},{"key":"e_1_2_1_36_1","first-page":"469","article-title":"O'Callaghan RJ","volume":"12","author":"Hobden JA","year":"1993","unstructured":"Hobden JA, Engel LS, Hill JM, Callegan MC, O'Callaghan RJ. Prednisolone acetate or prednisolone phosphate con-currently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993;12:469\u2013473.","journal-title":"Prednisolone acetate or prednisolone phosphate con-currently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.9.1856"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713689509033519"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.6.743"},{"key":"e_1_2_1_40_1","first-page":"3","article-title":"destruc-tion of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks","volume":"25","author":"Sansonetti PI Rupture, invasion and inflammatory","year":"2001","unstructured":"Sansonetti PI Rupture, invasion and inflammatory destruc-tion of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks. FEMS Microbiol Rev. 2001;25:3\u201314.","journal-title":"FEMS Microbiol Rev"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-146-12-3217"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3497-3501.1995"},{"key":"e_1_2_1_43_1","first-page":"S253","article-title":"Fleiszig SMJ","volume":"42","author":"Lee EJ","year":"2001","unstructured":"Lee EJ, Mendoza MN, Fleiszig SMJ. The relationship between corneal epithelial integrity and susceptibility to Pseudomonas aeruginosa infection in vivo. Invest Oph-thalmol Vis Sci. 2001;42: S253.","journal-title":"The relationship between corneal epithelial integrity and susceptibility to Pseudomonas aeruginosa infection in vivo. Invest Oph-thalmol Vis Sci"},{"key":"e_1_2_1_44_1","first-page":"488","article-title":"Berk RS","volume":"172","author":"Beisel KW","year":"1983","unstructured":"Beisel KW, Hazlett LD, Berk RS. Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa. Proc Soc Exp Biol Med. 1983;172:488\u2013491.","journal-title":"Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa. Proc Soc Exp Biol Med"},{"key":"e_1_2_1_45_1","first-page":"289","article-title":"Berk RS","volume":"16","author":"Kernacki KA","year":"1997","unstructured":"Kernacki KA, Fridman R, Hazlett LD, Lande MA, Berk RS. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infec-tions in naive and immunized mice. Curr Eye Res. 1997;16:289\u2013297.","journal-title":"In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infec-tions in naive and immunized mice. Curr Eye Res"},{"key":"e_1_2_1_46_1","first-page":"1371","article-title":"Berk RS","volume":"36","author":"Kernacki KA","year":"1995","unstructured":"Kernacki KA, Hobden JA, Hazlett LD, Fridman R, Berk RS. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Oph-thalmol Vis Sci. 1995;36:1371\u20131378.","journal-title":"In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Oph-thalmol Vis Sci"}],"container-title":["Current Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1076\/ceyr.27.5.289.17220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T01:11:01Z","timestamp":1770945061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1076\/ceyr.27.5.289.17220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1076\/ceyr.27.5.289.17220"],"URL":"https:\/\/doi.org\/10.1076\/ceyr.27.5.289.17220","relation":{},"ISSN":["0271-3683","1460-2202"],"issn-type":[{"value":"0271-3683","type":"print"},{"value":"1460-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}